Current Status of the Safety and Efficacy of Antidotes for Direct Oral Anticoagulants in Japan. [PDF]
JACC AsiaKodani E.
europepmc +1 more source
From empirical hemostasis to precision reversal: clinical challenges, technological innovations, and individualized strategies in anticoagulant-associated bleeding. [PDF]
Front Cardiovasc MedZheng W +6 more
europepmc +1 more source
Perioperative management of direct oral anticoagulant-treated patients who need urgent surgery. [PDF]
Res Pract Thromb HaemostCarlin S, Godoy A, Douketis J.
europepmc +1 more source
Severe Hemoptysis Caused by Right Inferior Pulmonary Vein Perforation During Circular-Array Pulsed-Field Ablation. [PDF]
JACC Case RepKishaba J +8 more
europepmc +1 more source
Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds [PDF]
Circulation, 2019 Deborah M, Siegal, Stuart J, Connolly
openaire +2 more sources
Anticoagulation Stewardship Program in the DOAC Era. [PDF]
J Clin MedNg JX, Tan SC, Koh PL, Yap ES.
europepmc +1 more source
Idarucizumab in the ‘real world’: possibilities and limitations
EP Europace, 2018 Steffel, Jan, Heidbüchel, Hein
openaire +4 more sources
Specific reversal agents for direct oral anticoagulants in neurosurgical emergencies - a systematic review. [PDF]
Res Pract Thromb HaemostZeller L +10 more
europepmc +1 more source
A UK-wide analysis of the use of reversal agents in 198 patients on direct oral anticoagulants prior to urgent procedures. [PDF]
Res Pract Thromb HaemostHaemSTAR Collaborators.
europepmc +1 more source
Post-Ablation Stroke Despite NOAC Use: Successful Reperfusion Therapy After Dabigatran Reversal with Incidental Discovery of a Large MCA Aneurysm-A Case Report. [PDF]
Neurol IntSari SM +7 more
europepmc +1 more source